Breast Cancer
Reports from University Medical Center Advance Knowledge in Breast Cancer
Published in Women's Health Weekly, March 15th, 2012
2012 MAR 15 -- Research findings, "CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome," are discussed in a new report. "Women classified as having triple-negative tumors have a poor prognosis. The importance of CD44(+)/CD24(-/low) (stem/progenitor cell-phenotype) in breast cancer patients has also been appreciated," scientists in Richmond, Virginia report.
"However, correlation between triple negativity and CD44(+)/CD24(-/low) with tumor recurrence remains elusive. In the present study, we evaluated tumor specimens of 50 breast cancer patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
A giant little step in cancer treatment opening up new therapeutic horizons - Bullous Pemphigoid
Data from D.C.C. Gan et al Provide New Insights into Bullous Pemphigoid - Cervical Cancer
Data from M.W. Luczak and Colleagues Advance Knowledge in Cervical Cancer - Breast Cancer
Data on Breast Cancer Detailed by Researchers at University of California - Breast Cancer
Data on Breast Cancer Reported by Researchers at Korea University Anam Hospital - Breast Cancer
Fewer women need repeat breast cancer surgeries with new service at University of Michigan - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
